| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |